Itovebi is supplied as a tablet in 2 dosage strengths: 3mg and 9mg. Patients should be selected for treatment based on the presence of 1 or more PIK3CA mutations in plasma specimens. The FDA has ...

The Breakthrough Therapy designation is supported by positive interim data from the phase 2b VANTAGE study (ClinicalTrials.gov Identifier: NCT05050136) that evaluated the efficacy and safety of ...

HealthDay News — Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a study presented at the annual meeting of the International ...

The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for elinzanetant for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.

The impact of Hurricane Helene has led to a temporary supply disruption at the Baxter facility in Marion, North Carolina. The facility manufactures a significant portion of IV solutions, irrigation ...

The Food and Drug Administration (FDA) has granted Fast Track designation to liafensine (DB104) for patients with treatment-resistant depression (TRD).